Middle East & Africa electronic drug delivery systems market is projected to register a substantial CAGR of 6.6% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027
Market Segmentation:
Middle East & Africa Electronic Drug Delivery Systems Market, By Type (Electronic Infusion Pumps, Electronic Injection Pens, Electronic Auto-Injectors, Electronic Inhalers, Electronic Capsules and Others), Component (Sensors, Wireless Communicator and Antennas, Micro Pumps and Flow Regulators, Drug Reservoir, Microcontroller and Others), Connectivity (Bluetooth Low Energy (BLE), Wi-Fi, Ethernet, NB-IoT and Others), System Type (Battery-Powered Systems, Rechargeable Systems), Application (Diabetes, Asthma and Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, Growth Hormone Therapy, Immunodeficiency Disease, Cardiovascular Disease, Thalassemia and Others), End User (Home Healthcare, Hospitals, Clinics, Ambulatory Centers and Others), Country (Saudi Arabia, South Africa, U.A.E., Israel, Egypt, Rest of Middle East & Africa) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the Middle East & Africa electronic drug delivery systems market are:

• High prevalence of various chronic disorders
• Technological advancement
Market Players

The key market players for Middle East & Africa electronic drug delivery systems market are listed below:
• AstraZeneca
• Merck KGaA
• Bayer AG
• AptarGroup, Inc.
• Novo Nordisk A/S.
• Medtronic
• Companion Medical
• Insulet Corporation
• BD
• B. Braun Melsungen AG